Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists
Background: Recent approvals for novel agents such as the small molecule Janus kinase inhibitors (JAKi), combined with the advent of biosimilars has widened the gamut of available therapeutic options in the treatment of rheumatoid arthritis (RA). This combined with the introduction of mandatory non-...
Gorde:
Egile Nagusiak: | , , , , , , |
---|---|
Formatua: | Liburua |
Argitaratua: |
Centro de Investigaciones y Publicaciones Farmaceuticas,
2021-09-01T00:00:00Z.
|
Gaiak: | |
Sarrera elektronikoa: | Connect to this object online. |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Internet
Connect to this object online.3rd Floor Main Library
Sailkapena: |
A1234.567 |
---|---|
Alea 1 | Eskuragarri |